At Cambrex, it’s our people that set us apart. We are passionate about what we do and this translates into an expert team that you’ll enjoy working with.
Our people add a dimension that makes Cambrex integral to your business. As your partner, we share your goal and drive to advance your small molecule therapeutics to market. This is why our customers work with us for the long-term.
Steven M. KloskPresident and Chief Executive Officer
Mr. Klosk joined Cambrex in 1992 and was elected President and Chief Executive Officer and became a member of the Board in May 2008. In 2007 he was appointed Executive Vice President and Chief Operating Officer and assumed the responsibility of the Pharmaceutical business. Between 2005 and 2007, Mr. Klosk served as Executive Vice President and Chief Operating Officer of the Pharma and BioPharmaceutical Business Unit. Between 1992 and 2005, he held positions of increasing responsibility including Executive Vice President-Administration.
Shawn P. CavanaghExecutive Vice President and Chief Operating Officer
Mr. Cavanagh joined Cambrex in January 2011 and currently serves as Executive Vice President and Chief Operating Officer. Previously Mr. Cavanagh held several senior positions within Cambrex from 1999 to 2007, including President of Cambrex Bioproducts. Mr. Cavanagh joined Lonza in 2007 when the company acquired the Bioproducts business. Prior to joining Cambrex Bioproducts, Mr. Cavanagh held various management and engineering positions with FMC Corporation.
Samantha M. HanleyVice President, General Counsel and Secretary
Ms. Hanley joined Cambrex in April 2009 and has served as Assistant General Counsel and Assistant Secretary since January 2013 and as Vice President, General Counsel and Secretary since February 2015.
Ms. Hanley previously held the position of Senior Intellectual Property/Corporate Counsel and Assistant Secretary. Prior to joining Cambrex, Ms. Hanley worked at Alpharma Pharmaceuticals as Director of Intellectual Property and was an Associate with Lerner, David, Littenberg, Krumholtz & Mentlik, LLP, an intellectual property law firm.
Gregory P. SargenChief Financial Officer and Executive Vice President, Corporate Development and Strategy
Mr. Sargen joined Cambrex in February 2003 and currently serves as Executive Vice President and Chief Financial Officer since September 2018 and Executive Vice President, Corporate Development and Strategy since January 2017. He previously served as Executive Vice President and Chief Financial Officer from January 2011 to January 2017, and Vice President and Chief Financial Officer since February 2007. Mr. Sargen previously held the position of Vice President, Finance.
Prior to joining Cambrex, Mr. Sargen was with Exp@nets, Inc., from 1999 through 2002, serving in the roles of Executive Vice President, Finance/Chief Financial Officer and Vice President/Corporate Controller. From 1996 to 1998, he was with Fisher Scientific International’s Chemical Manufacturing Division, serving in the roles of Vice President, Finance and Controller. Mr. Sargen has also held various positions in finance, accounting and audit with Merck & Company, Inc., Heat and Control, Inc., and Deloitte & Touche.